Amp Continues to Add ARRY to its Portfolio This Week


Ahead of its presentations at the European Society for Medical Oncology (ESMO) annual meeting this week, Amp added a stake in Array Biopharma (ARRY) to its hypothetical fund earlier in the week, and is increasing that stake today.


0 comments